Desq Long
Sign in
SEC FORM 4
—

Latigo Biotherapeutics, Inc. (LTGO)

Acquisition (code C) of 177,978 shares; price not stated (see filing).

Reporting Person Sanofi · Transaction Code C

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-345826 · filed 2026-08-12 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Latigo Biotherapeutics, Inc. (LTGO)." Disclosed 2026-08-12. https://desqlong.com/cards/0001193125-26-345826-2 (retrieved 2026-09-26).